Immediate Impact

4 from Science/Nature 50 standout
Sub-graph 1 of 25

Citing Papers

Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction
2023 Standout
Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)
2022 Standout
7 intermediate papers

Works of Kazuyasu Maruyama being referenced

Bezafibrate prevents hepatic stellate cell activation and fibrogenesis in a murine steatohepatitis model, and suppresses fibrogenic response induced by transforming growth factor‐β1 in a cultured stellate cell line
2008
Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARδ agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet
2006
and 1 more

Author Peers

Author Last Decade Papers Cites
Kazuyasu Maruyama 102 87 227 213 112 27 521
M. Paubert-Braquet 51 120 183 57 97 26 596
Terumasa Hashimoto 68 26 223 79 32 35 582
Mi-Hye Kwon 25 63 232 55 114 22 546
Hanumanthappa Nandeesha 65 152 124 58 204 30 565
Masami Ohmori 127 39 110 26 51 38 549
Mohamed El‐Shafey 27 13 165 59 59 26 470
Toshihiko Uematsu 113 12 179 89 21 48 637
Pankaj Prasun 41 7 261 126 61 29 514
Xinli Zhou 82 7 206 121 209 34 525
Sylvia Jacob 77 5 305 245 134 36 637

All Works

Loading papers...

Rankless by CCL
2026